川发龙蟒(002312) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥2,084,436,086.14, representing a 24.70% increase compared to ¥1,671,591,008.24 in the same period last year[4] - The net profit attributable to shareholders was ¥103,260,371.64, showing a slight decrease of 0.24% from ¥103,508,332.96 year-on-year[4] - The net profit after deducting non-recurring gains and losses increased by 3.93% to ¥103,486,070.29 from ¥99,570,024.53 in the previous year[4] - Operating profit for Q1 2025 was ¥127,391,867.59, compared to ¥119,071,276.34 in Q1 2024, reflecting an increase of about 6.0%[18] - Net profit for Q1 2025 was ¥102,600,001.57, slightly down from ¥104,031,197.59 in Q1 2024, indicating a decrease of approximately 1.4%[19] - Total operating costs for Q1 2025 were ¥1,984,897,255.68, up from ¥1,612,442,418.54 in Q1 2024, marking an increase of approximately 23.1%[17] Cash Flow - The net cash flow from operating activities was -¥372,891,262.18, a decline of 36.33% compared to -¥273,528,844.19 in the same period last year[4] - Cash flow from operating activities showed a net outflow of ¥372,891,262.18 in Q1 2025, worsening from a net outflow of ¥273,528,844.19 in Q1 2024[19] - Financing activities generated a net cash inflow of ¥1,421,022,181.35 in Q1 2025, compared to ¥595,358,141.83 in Q1 2024, an increase of approximately 138.5%[20] Assets and Liabilities - Total assets at the end of the reporting period reached ¥20,102,339,629.16, up 9.44% from ¥18,368,620,911.46 at the end of the previous year[4] - As of March 31, 2025, the company reported total assets of RMB 20.102 billion, an increase from RMB 18.369 billion at the beginning of the period, reflecting a growth of approximately 9.4%[15] - Total liabilities rose to RMB 10.342 billion from RMB 8.712 billion, indicating an increase of approximately 18.7%[15] - The company’s equity attributable to shareholders reached RMB 9.554 billion, up from RMB 9.449 billion, showing a slight increase of about 1.1%[16] Investments - The company’s investment income decreased by 42.57% to ¥30,923,580.66 from ¥53,848,624.46 year-on-year, primarily due to changes in the profits of joint ventures[9] - The company acquired a 10% stake in Sichuan Development Tiansheng Mining Co., Ltd. for RMB 263.266 million, securing access to the Xiaogou Phosphate Mine with a total resource of 401 million tons and a designed production capacity of 5.5 million tons per year[12] - The company’s subsidiary, Nanzhang Longmang, purchased 60% of Tianbao Animal Nutrition Technology Co., Ltd. for RMB 432 million, enhancing its position in the feed-grade dicalcium phosphate industry[13] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 234,088[10] Other Financial Metrics - The weighted average return on net assets was 1.08%, a decrease of 0.05 percentage points from 1.13% in the previous year[4] - The company reported a 95.87% increase in receivables financing to ¥187,069,740.95 from ¥95,506,138.00, attributed to increased operating revenue[8] - The company’s cash and cash equivalents increased to RMB 3.603 billion from RMB 2.951 billion, representing a growth of about 22.1%[14] - The company’s current assets totaled RMB 6.575 billion, compared to RMB 5.216 billion at the beginning of the period, marking an increase of approximately 26.1%[14] - The company’s long-term borrowings increased significantly to RMB 4.346 billion from RMB 2.961 billion, reflecting an increase of approximately 46.6%[15] - The company’s inventory decreased slightly to RMB 1.143 billion from RMB 1.175 billion, a decline of about 2.7%[14] - The company’s accounts payable rose to RMB 1.240 billion from RMB 1.032 billion, indicating an increase of approximately 20.1%[15] - Research and development expenses decreased to ¥27,410,561.93 in Q1 2025 from ¥38,268,132.18 in Q1 2024, a reduction of about 28.4%[17] - Cash and cash equivalents at the end of Q1 2025 totaled ¥2,813,412,544.49, a decrease from ¥2,870,653,841.63 at the end of Q1 2024[20] - The basic and diluted earnings per share remained stable at ¥0.05 for both Q1 2025 and Q1 2024[19]